Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Cash from Investing Activities (2016 - 2026)

Elevance Health (ELV) has disclosed Cash from Investing Activities for 16 consecutive years, with $464.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 128.33% to $464.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 billion through Dec 2025, up 73.99% year-over-year, with the annual reading at -$1.3 billion for FY2025, 73.99% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $464.0 million at Elevance Health, up from -$1.2 billion in the prior quarter.
  • The five-year high for Cash from Investing Activities was $464.0 million in Q4 2025, with the low at -$4.9 billion in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$1.3 billion, with a median of -$1.1 billion recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 1717.98% in 2021, then skyrocketed 129.92% in 2022.
  • Over 5 years, Cash from Investing Activities stood at -$966.0 million in 2021, then soared by 129.92% to $289.0 million in 2022, then plummeted by 456.06% to -$1.0 billion in 2023, then tumbled by 59.18% to -$1.6 billion in 2024, then soared by 128.33% to $464.0 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $464.0 million, -$1.2 billion, and -$687.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.